Recursion Pharmaceuticals has raised $60 million to step up its artificial intelligence-enabled drug discovery activities. The series B equips Recursion to move beyond its initial focus on repurposing ...
Artificial intelligence drug discovery company Recursion Pharmaceuticals has announced an oversubscribed Series D funding round totaling $239 million. Headlining the raise is a strategic partnership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results